- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03033953
Effects of Native Whey or Milk Supplementation on Adaptations to 12 Weeks of Strength Training in Young and Elderly
Effects of Native Whey and Milk Supplementation on Changes in Muscle Mass and Strength After 12 Weeks of Strength Training in Young and Elderly
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than milk. Of special interest is the higher amounts of the highly anabolic amino acid leucine in native whey.
The higher levels of leucine can be of great interest for elderly individuals as some studies in elderly has shown an anabolic resistance to the effects of protein feeding and strength training. By increasing levels of leucine one might overcome this anabolic resistance in the elderly.
The aim of this double-blinded, randomized, partial cross-over study is to compare the changes in muscle hypertrophy and strength after a 11 (elderly) or 12 (young) week training intervention with daily supplementation of either 2x20g of native whey or milk proteins in young and elderly individuals. In order to explain potential differences between supplements an acute study investigating acute responses in blood amino acid concentrations and intracellular signalling is planned, in a subgroup of participants, before and after the training intervention.
The investigators hypothesize that native whey will induce greater muscle hypertrophy and strength gains than milk.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Oslo, Noruega, 0863
- Norwegian School of Sport Sciences
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Healthy in the sense that they can conduct training and testing
- Able to understand Norwegian language written and oral
- Between 20 and 45, or above 70 years of age
Exclusion Criteria:
- Diseases or injuries contraindicating participation
- Use of dietary supplements (e.g. proteins, vitamins and creatine)
- Lactose intolerance
- Allergy to milk
- Allergy towards local anesthetics (xylocain)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Comparador de Placebo: Milk supplementation
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g milk protein.
|
|
Experimental: Native whey
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g native whey protein.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Lean mass
Prazo: Before the training intervention
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
Before the training intervention
|
Lean mass
Prazo: After 11-12 weeks of strength training
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
After 11-12 weeks of strength training
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Thigh muscle cross sectional area
Prazo: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
Thigh muscle cross sectional area
Prazo: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
Pectoralis muscle cross sectional area
Prazo: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
Pectoralis muscle cross sectional area
Prazo: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
Arm cross sectional area
Prazo: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
Arm cross sectional area
Prazo: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
Thickness of the lateral vasti
Prazo: Before the training intervention
|
Measured by ultrasound
|
Before the training intervention
|
Thickness of the lateral vasti
Prazo: After 11-12 weeks of strength training
|
Measured by ultrasound
|
After 11-12 weeks of strength training
|
1 repetition maximum in leg press
Prazo: Before the training intervention
|
Before the training intervention
|
|
1 repetition maximum in leg press
Prazo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
1 repetition maximum in bench press
Prazo: Before the training intervention
|
Before the training intervention
|
|
1 repetition maximum in bench press
Prazo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Prazo: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Prazo: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Prazo: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Prazo: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Prazo: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Prazo: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Plasma amino acid concentration
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Plasma amino acid concentration
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Muscle force generating capacity change from baseline
Prazo: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
Muscle force generating capacity change from baseline
Prazo: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Serum glucose
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum glucose
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum insulin
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum insulin
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum urea
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum urea
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum creatine kinase
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum creatine kinase
Prazo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Tumor necrosis factor alfa messenger ribonucleic acid (mRNA)
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Tumor necrosis factor alfa mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Tumor necrosis factor alfa mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Tumor necrosis factor alfa mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 6 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 6 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 6 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 6 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 8 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 8 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 8 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 8 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1b mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 1b mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 1b mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1b mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1 Receptor Antagonist mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 1 Receptor Antagonist mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 1 Receptor Antagonist mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1 Receptor Antagonist mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 2 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 2 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 2 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 2 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 4 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 4 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 4 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 4 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 10 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 10 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 10 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 10 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Cholesterol 25-Hydroxylase mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Cholesterol 25-Hydroxylase mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Cholesterol 25-Hydroxylase mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Cholesterol 25-Hydroxylase mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 8 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 8 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 8 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 8 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 17D mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 17D mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 17D mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 17D mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 3 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 3 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 3 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 3 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 5 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 5 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 5 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 5 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Uncoupling Protein 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Uncoupling Protein 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Uncoupling Protein 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Uncoupling Protein 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Matrix Metallopeptidase 9 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Matrix Metallopeptidase 9 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Matrix Metallopeptidase 9 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Matrix Metallopeptidase 9 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Toll Like Receptor 2 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Toll Like Receptor 2 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Toll Like Receptor 2 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Toll Like Receptor 2 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 3 Member 2 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 3 Member 2 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 3 Member 2 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 3 Member 2 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 7 Member 5 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 7 Member 5 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 7 Member 5 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 7 Member 5 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 36 Member 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 36 Member 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 36 Member 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 36 Member 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 38 Member 2 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 38 Member 2 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 38 Member 2 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 38 Member 2 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Atrogin-1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Atrogin-1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Atrogin-1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Atrogin-1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box Protein O1A mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Forkhead Box Protein O1A mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Forkhead Box Protein O1A mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box Protein O1A mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box O3 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Forkhead Box O3 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Forkhead Box O3 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box O3 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 7 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 7 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 7 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 7 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 2 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 2 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 2 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 2 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 1mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Prazo: 30 min after exercise and protein intake, after 11-12 weeks of strength training
|
30 min after exercise and protein intake, after 11-12 weeks of strength training
|
|
Fasting cholesterol (only in elderly)
Prazo: Before training intervention
|
Before training intervention
|
|
Fasting cholesterol (only in elderly)
Prazo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Fasting triglycerides (only in elderly)
Prazo: Before training intervention
|
Before training intervention
|
|
Fasting triglycerides (only in elderly)
Prazo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Fasting LDL (only in elderly)
Prazo: Before training intervention
|
Before training intervention
|
|
Fasting LDL (only in elderly)
Prazo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Fasting HDL (only in elderly)
Prazo: Before training intervention
|
Before training intervention
|
|
Fasting HDL (only in elderly)
Prazo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- Tine 12wk
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Treinamento de força
-
University of British ColumbiaSocial Sciences and Humanities Research Council of Canada; Michael Smith Foundation... e outros colaboradoresConcluídoViolência baseada no gênero | Intervenção de divulgaçãoCanadá
-
Khon Kaen UniversityConcluído
-
The Hong Kong Polytechnic UniversityConcluído
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecrutamento
-
IRCCS Centro Neurolesi "Bonino-Pulejo"ConcluídoÉ Possível Que Amadeo Garanta Uma Maior Melhora Clínica Comparada a uma Terapia Ocupacional Graças ao Fortalecimento da Plasticidade CerebralItália
-
The University of Tennessee, KnoxvilleConcluídoProfessores de matemática (2ª a 8ª séries) | Alunos de matemática (2ª a 8ª séries)Estados Unidos
-
Università degli Studi di SassariConcluídoEsclerose múltipla | Fadiga | FraquezaItália
-
Shirley Ryan AbilityLabU.S. Department of EducationAtivo, não recrutandoLesões da Medula Espinhal
-
NHS Greater Glasgow and ClydeUniversity of GlasgowRecrutamentoLesão Cerebral AdquiridaReino Unido
-
University of Maryland, College ParkNational Institute of Mental Health (NIMH); Medical Research Council, South...ConcluídoTranstornos Relacionados a Substâncias | Depressão | Tuberculose | HIV | Distúrbio de saúde mental | Distúrbio mental | Utilização de cuidados de saúde | Adesão e Cumprimento do Tratamento | Estigma social | Atitude do pessoal de saúde | Agentes Comunitários de Saúde | Prestação de cuidados de saúdeÁfrica do Sul